Skip to main content
OpenTrials

Clinical trial condition

Brain Diseases, Metabolic, Inborn

Explore clinical trials studying Brain Diseases, Metabolic, Inborn. Study availability and eligibility vary by location and protocol.

949 public trials 197 recruiting studies
Refine in advanced search Browse all conditions

Brain Diseases, Metabolic, Inborn trial results

Completed

High Dose or High Dose Frequency Study of Alglucosidase Alfa

NCT00483379

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations
  • Birmingham, Alabama, United States
  • Stanford, California, United States
  • Washington D.C., District of Columbia, United States
  • Chicago, Illinois, United States
View Trial Details
Completed

Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease

NCT00074932

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • Colorado Health Science Center Aurora, Colorado, United States
  • Galichia Heart Hospital Wichita, Kansas, United States
  • Genzyme Medical Information Cambridge, Massachusetts, United States
  • Freeman Health Systems Joplin, Missouri, United States
View Trial Details
Completed

Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602

NCT00125879

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +12 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Shands Hospital at the University of Florida Gainesville, Florida, United States
  • Miami Children's Hospital Miami, Florida, United States
  • Emory University Medical Genetics Decatur, Georgia, United States
View all 14 locations
View Trial Details

Related conditions